Annals of Oncology

in this issue

In this issue
Ann Oncol 2007 18: 1427; doi:10.1093/annonc/mdm421 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials

R Brown and R Glasspool

Epigenetic modulation of resistance to chemotherapy?
Ann Oncol 2007 18: 1429-1430; doi:10.1093/annonc/mdm415 [Extract] [Full Text] [PDF] [Request Permissions]  

C. Tondini, P Fenaroli, and R Labianca

Breast cancer follow-up: just a burden, or much more?
Ann Oncol 2007 18: 1431-1432; doi:10.1093/annonc/mdm380 [Extract] [Full Text] [PDF] [Request Permissions]  

MP Coleman

Not credible: a subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Ann Oncol 2007; 18 Suppl 3: pp 1–75)
Ann Oncol 2007 18: 1433-1435; doi:10.1093/annonc/mdm363 [Extract] [Full Text] [PDF] [Request Permissions]  

review

Get checked abstract MHJ van den Beuken-van Everdingen, JM de Rijke, AG Kessels, HC Schouten, M van Kleef, and J Patijn

Prevalence of pain in patients with cancer: a systematic review of the past 40 years
Annals of Oncology Advance Access published on March 12, 2007
Ann Oncol 2007 18: 1437-1449; doi:10.1093/annonc/mdm056 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract M Devetten and JO Armitage

Hematopoietic cell transplantation: progress and obstacles
Annals of Oncology Advance Access published on March 12, 2007
Ann Oncol 2007 18: 1450-1456; doi:10.1093/annonc/mdm064 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract DB Cornelio, R Roesler, and G Schwartsmann

Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 2007 18: 1457-1466; doi:10.1093/annonc/mdm058 [Abstract] [Full Text] [PDF] [Request Permissions]  

original articles

breast cancer

Get checked abstract P Donnelly, L Hiller, S Bathers, S Bowden, and R Coleman

Questioning specialists’ attitudes to breast cancer follow-up in primary care
Annals of Oncology Advance Access published on May 24, 2007
Ann Oncol 2007 18: 1467-1476; doi:10.1093/annonc/mdm193 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract R Conforti, T Boulet, G Tomasic, E Taranchon, R Arriagada, M Spielmann, M Ducourtieux, JC Soria, T Tursz, S Delaloge, S Michiels, and F Andre

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials
Annals of Oncology Advance Access published on May 21, 2007
Ann Oncol 2007 18: 1477-1483; doi:10.1093/annonc/mdm209 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract O Camara, M Rengsberger, A Egbe, A Koch, M Gajda, U Hammer, C Jörke, C Rabenstein, M Untch, and K Pachmann

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
Ann Oncol 2007 18: 1484-1492; doi:10.1093/annonc/mdm206 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract KJ Dedes, TD Szucs, P Imesch, A Fedier, MK Fehr, and D Fink

Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial
Ann Oncol 2007 18: 1493-1499; doi:10.1093/annonc/mdm185 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors

Get checked abstract C Pisano, L Vesci, R Foderà, FF Ferrara, C Rossi, M De Cesare, V Zuco, G Pratesi, R Supino, and F Zunino

Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models
Annals of Oncology Advance Access published on August 13, 2007
Ann Oncol 2007 18: 1500-1505; doi:10.1093/annonc/mdm195 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract I Jahan, J Fujimoto, S. Mahfuzul Alam, E Sato, H Sakaguchi, and T Tamaya

Role of protease activated receptor-2 in tumor advancement of ovarian cancers
Ann Oncol 2007 18: 1506-1512; doi:10.1093/annonc/mdm190 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C Coutant, E Barranger, A Cortez, D Dabit, S Uzan, JF Bernaudin, and E Darai

Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer
Ann Oncol 2007 18: 1513-1517; doi:10.1093/annonc/mdm192 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors

Get checked abstract F Ruthotto, F Papendorf, G Wegener, G Unger, B Dlugosch, F Korangy, MP Manns, and TF Greten

Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer
Ann Oncol 2007 18: 1518-1522; doi:10.1093/annonc/mdm200 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies

Get checked abstract MT Voso, E Fabiani, F D'Alo', F Guidi, A Di Ruscio, S Sica, L Pagano, M Greco, S Hohaus, and G Leone

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes
Ann Oncol 2007 18: 1523-1528; doi:10.1093/annonc/mdm191 [Abstract] [Full Text] [PDF] [Request Permissions]  

miscellaneous tumors

Get checked abstract M Candelaria, D Gallardo-Rincón, C Arce, L Cetina, JL Aguilar-Ponce, Ó Arrieta, A González-Fierro, A Chávez-Blanco, E de la Cruz-Hernández, MF Camargo, C Trejo-Becerril, E Pérez-Cárdenas, C Pérez-Plasencia, L Taja-Chayeb, T Wegman-Ostrosky, A Revilla-Vazquez, and A Dueñas-González

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
Ann Oncol 2007 18: 1529-1538; doi:10.1093/annonc/mdm204 [Abstract] [Full Text] [PDF] [Request Permissions]  

palliative care

Get checked abstract M Sanjo, M Miyashita, T Morita, K Hirai, M Kawa, T Akechi, and Y Uchitomi

Preferences regarding end-of-life cancer care and associations with good-death concepts: a population-based survey in Japan
Annals of Oncology Advance Access published on July 28, 2007
Ann Oncol 2007 18: 1539-1547; doi:10.1093/annonc/mdm199 [Abstract] [Full Text] [PDF] [Request Permissions]  

original article

Get checked abstract C Sessa, A Perotti, A Lladò, S Cresta, G Capri, M Voi, S Marsoni, I Corradino, and L Gianni

Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly schedule
Ann Oncol 2007 18: 1548-1553; doi:10.1093/annonc/mdm198 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract E Steliarova-Foucher, V Arndt, DM Parkin, F Berrino, and H Brenner

Timely disclosure of progress in childhood cancer survival by ‘period’ analysis in the Automated Childhood Cancer Information System
Annals of Oncology Advance Access published on August 13, 2007
Ann Oncol 2007 18: 1554-1560; doi:10.1093/annonc/mdm194 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract Hermann Brenner, Eva Steliarova-Foucher, and Volker Arndt

Up-to-date monitoring of childhood cancer long-term survival in Europe: methodology and application to all forms of cancer combined
Annals of Oncology Advance Access published on July 28, 2007
Ann Oncol 2007 18: 1561-1568; doi:10.1093/annonc/mdm186 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract H Brenner, JW Coebergh, DM Parkin, I Izarzugaza, J Clavel, V Arndt, and E Steliarova-Foucher

Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas
Annals of Oncology Advance Access published on July 28, 2007
Ann Oncol 2007 18: 1569-1577; doi:10.1093/annonc/mdm187 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor

G Facchini, M Caraglia, G Nasti, A Ottaiano, R Franco, A La Mura, F Fulciniti, M Libutti, M Ruberto, M Marra, A Budillon, and RV Iaffaioli

Small tumor of the medial breast presenting with a contralateral lymph node involvement detected on positron emission tomography scan
Ann Oncol 2007 18: 1579-1580; doi:10.1093/annonc/mdm403 [Extract] [Full Text] [PDF] [Request Permissions]  

C Wick, M Egger, S Trelle, P Jüni, and MF Fey

The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry
Ann Oncol 2007 18: 1580-1582; doi:10.1093/annonc/mdm402 [Extract] [Full Text] [PDF] [Request Permissions]  

S Boeck, A Wollenberg, and V Heinemann

Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib
Ann Oncol 2007 18: 1582-1583; doi:10.1093/annonc/mdm420 [Extract] [Full Text] [PDF] [Request Permissions]  

B Vincenzi, A Calvieri, D Santini, V Altomare, and G Tonini

Occasional FDG–PET recognition of in situ breast cancer
Ann Oncol 2007 18: 1584-1585; doi:10.1093/annonc/mdm418 [Extract] [Full Text] [PDF] [Request Permissions]  

B Jönsson, F Lichtenberg, and N Wilking

Reply to ‘Not credible: a subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)’ by Michel P Coleman
Ann Oncol 2007 18: 1585-1587; doi:10.1093/annonc/mdm397 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.